The postoperative analgesic efficacy of liposomal bupivacaine versus long-acting local anaesthetics for peripheral nerve and field blocks: A systematic review and meta-analysis, with trial sequential analysis
- PMID: 37038770
- PMCID: PMC10860892
- DOI: 10.1097/EJA.0000000000001833
The postoperative analgesic efficacy of liposomal bupivacaine versus long-acting local anaesthetics for peripheral nerve and field blocks: A systematic review and meta-analysis, with trial sequential analysis
Abstract
Background: Liposomal bupivacaine is claimed by the manufacturer to provide analgesia for up to 72 h postoperatively.
Objectives: To compare the postoperative analgesic efficacy of liposomal bupivacaine versus long-acting local anaesthetics for peripheral nerve or field blocks.
Design: A systematic review and meta-analysis with trial sequential analysis.
Data sources: MEDLINE, Embase and Web of Science, among others, up to June 2022.
Eligibility criteria: We retrieved randomised controlled trials comparing liposomal bupivacaine versus bupivacaine, levobupivacaine or ropivacaine for peripheral nerve and field blocks after all types of surgery. Our primary endpoint was rest pain score (analogue scale 0 to 10) at 24 h. Secondary endpoints included rest pain score at 48 and 72 h, and morphine consumption at 24, 48 and 72 h.
Results: Twenty-seven trials including 2122 patients were identified. Rest pain scores at 24 h were significantly reduced by liposomal bupivacaine with a mean difference (95% CI) of -0.9 (-1.4 to -0.4), I2 = 87%, P < 0.001. This reduction in pain scores persisted at 48 h and 72 h with mean differences (95% CI) of -0.7 (-1.1 to -0.3), I2 = 82%, P = 0.001 and -0.7 (-1.1 to -0.3), I2 = 80%, P < 0.001, respectively. There were no differences in interval morphine consumption at 24 h ( P = 0.15), 48 h ( P = 0.15) and 72 h ( P = 0.07). The quality of evidence was moderate.
Conclusions: There is moderate level evidence that liposomal bupivacaine reduces rest pain scores by 0.9 out of 10 units, when compared with long-acting local anaesthetics at 24 hours after surgery, and by 0.7 up to 72 hours after surgery.
Copyright © 2023 European Society of Anaesthesiology and Intensive Care. Unauthorized reproduction of this article is prohibited.
Figures



Comment in
-
Liposomal bupivacaine: Defining efficacy, how effective is effective?Eur J Anaesthesiol. 2023 Sep 1;40(9):622-623. doi: 10.1097/EJA.0000000000001879. Eur J Anaesthesiol. 2023. PMID: 37530714 No abstract available.
References
-
- Chou R, Gordon DB, de Leon-Casasola OA, et al. . Management of postoperative pain: a clinical practice guideline from the American Pain Society, the American Society of Regional Anesthesia and Pain Medicine, and the American Society of Anesthesiologists’ Committee on Regional Anesthesia, Executive Committee, and Administrative Council. J Pain 2016; 17:131–157. - PubMed
-
- Baeriswyl M, Kirkham KR, Jacot-Guillarmod A, et al. . Efficacy of perineural vs systemic dexamethasone to prolong analgesia after peripheral nerve block: a systematic review and meta-analysis. Br J Anaesth 2017; 119:183–191. - PubMed
-
- Albrecht E, Kern C, Kirkham KR. A systematic review and meta-analysis of perineural dexamethasone for peripheral nerve blocks. Anaesthesia 2015; 70:71–83. - PubMed
-
- Albrecht E, Reynvoet M, Fournier N, et al. . Dose-response relationship of perineural dexamethasone for interscalene brachial plexus block: a randomised, controlled, triple-blind trial. Anaesthesia 2019; 74:1001–1008. - PubMed
-
- Albrecht E, Chin KJ. Advances in regional anaesthesia and acute pain management: a narrative review. Anaesthesia 2020; 75: (Suppl 1): e101–e110. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical